Show Up R.e.a.l.
Be Respectful, Empathetic, Authentic, and Listen to learn.
We are united in our mission to address the underlying cause of severe diseases.
We are deeply committed to patients and motivated by an unwavering belief that our team can do what’s never been done before. We are united in our mission to address the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. At the same time, we are caring, fun-loving and humble humans. We embrace diversity within a unique culture that is defined by our values.
Stoke employees are authentic, transparent, diverse and inclusive. Every person is invited to provide input which is considered in decision-making.
We are dedicated, persistent and work with a sense of urgency fueled by our passion to make a difference for patients.
We are purposeful about building shared experiences and fun into our work to balance the seriousness of our scientific endeavors.
Stoke was co-founded in 2014 by Professor Adrian Krainer, Ph.D. and Isabel Aznarez, Ph.D. who aimed to use their groundbreaking science targeting pre-mRNA splicing to develop precision medicines that treat the underlying cause of genetic diseases.
Learn about the talented individuals whose experience and mentorship are guiding Stoke toward realizing its full potential.
The scientific and business leaders on our Board know what it takes to deliver targeted therapeutics to patients, drawing on their diverse experience leading companies from startup through maturity.
At Stoke, we have built a diverse and inclusive team that is fueling our success.
Does the idea of making an impact for patients with severe disease light a fire within you? Learn more about opportunities to join our team.